Disease and Immune related mRNAs
-
R1020 EZ Cap™ EPO mRNA (ψUTP)2 CitationSummary: Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation. -
R2011 Human p53 circRNASummary: Circular RNA expressing human p53 protein -
R1035 EZ Cap™ Fdx1 mRNASummary: Fdx1 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1038 EZ Cap™ Human P16 mRNASummary: Human p16 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1039 EZ Cap™ Human P16 mRNA (ψUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1040 EZ Cap™ Human P16 mRNA (5-moUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1041 EZ Cap™ Mouse P16 mRNASummary: Mouse p16 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1042 EZ Cap™ Mouse P16 mRNA (ψUTP)Summary: Mouse p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

